Open access · US-GOV via ClinicalTrials.gov Clinical trial

Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)

Authors not listed

RenJi Hospital · 2020

Cellular senescence Human Randomized controlled trial

Abstract

This study aims to establish an ambispective cohort platform centered on the pathological axis of "sarcopenia-metabolic disorders-aging progression", integrating multimodal data including demographic characteristics, lifestyle factors, clinical phenotypes, laboratory tests, medical imaging, and biospecimens. Namely 'Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)'.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-12 MST

Cite this

APA

Anonymous. (2020). Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE). <em>RenJi Hospital</em>. https://clinicaltrials.gov/study/NCT07205510

Vancouver

Anonymous. Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE). RenJi Hospital. 2020.

BibTeX

@misc{anon2020Sarcop, title = {Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)}, author = {Anonymous}, journal = {RenJi Hospital}, year = {2020}, }